News

An Emerging Tech Center: Oklahoma City notable home-grown startups in Innovation Magazine Copyright © 2016 | Innovation America Accele BioPharma (founded in 2011) — Biotechnology business accelerator located in the University Research Park, formed to create a capital-efficient mechanism to identify, finance and manage groundbreaking early stage life science technologies. http://accelebio.com Analytical Research Laboratories/DNA Solutions/The KupiecRead more

Just when she lined up potential opportunities with three Florida biotech companies, Carol Curtis’ husband was transferred to Oklahoma City. Call it serendipity.

Robert Broyles received $218,000 to advance his business, and he aims to turn it into more than $1 million for Oklahoma City-based EpimedX.

Robert Broyles, in his work at the OU Health Science Center and National Institutes of Health, discovered that a molecule called ferritin-H would likely cause the switch back to fetal hemoglobin.

On this week’s Oklahoma Innovations radio show, learn how researchers at EpimedX have disdovered a safe plant growth factor with the potential to effectively prevent the manifestations of sickle cell disease.

i2E client EpmedX and its co-founder, Dr. Robert Broyles, were recently featured in the April edition of Oklahoma Magazine.

The nonprofit i2E Inc. has approved Oklahoma City-based EpimedX LLC for $200,000 in matching financing through its Concept Fund program.

Oklahoma City-based EpimedX, LLC., has been approved for a matching financing round of $200,000 from i2E, Inc., through the Concept Fund.

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the U.S.

Oklahoma City’s EpimedX is tackling a devastating genetic disease that affects millions of people around the world.